Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Decensi

Showing results (61-70 of 91) with videos related to

Pageof 10
Sort By:
European Journal of Cancer (Oxford, England : 1990)|September 24, 1999
Effect of tamoxifen on lipoprotein(a) and insulin-like growth factor-I (IGF-I) in healthy womenA Decensi, C Robertson, B Ballardini, et al.
Leukemia|April 6, 2012
N-(4-hydroxyphenyl)retinamide promotes apoptosis of resting and proliferating B-cell chronic lymphocytic leukemia cells and potentiates fludarabine and ABT-737 cytotoxicityS Bruno, F Ghiotto, C Tenca, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 20, 2013
Association of molecular subtypes with Ki-67 changes in untreated breast cancer patients undergoing pre-surgical trialsS Gandini, A Guerrieri-Gonzaga, G Pruneri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 19, 2010
Prognostic significance of Ki-67 labeling index after short-term presurgical tamoxifen in women with ER-positive breast cancerA DeCensi, A Guerrieri-Gonzaga, S Gandini, et al.
Nuklearmedizin. Nuclear Medicine|July 14, 2015
18F-FDG PET/CT is a prognostic biomarker in patients affected by bone metastases from breast cancer in comparison with 18F-NaF PET/CTA Piccardo, M Puntoni, S Morbelli, et al.
Breast Cancer Research and Treatment|January 5, 2002
Effect of low dose tamoxifen on the insulin-like growth factor system in healthy womenB Bonanni, H Johansson, S Gandini, et al.
Breast Cancer Research and Treatment|May 18, 1999
Effect of fenretinide on bone mineral density and metabolism in women with early breast cancerA Decensi, R Torrisi, A Gozza, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Effect of blood tamoxifen concentrations on surrogate biomarkers in a trial of dose reduction in healthy womenA Decensi, S Gandini, A Guerrieri-Gonzaga, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 6, 2001
Correlation between tamoxifen elimination and biomarker recovery in a primary prevention trialA Guerrieri-Gonzaga, L Baglietto, H Johansson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 13, 2015
Long-term effects of inhaled budesonide on screening-detected lung nodulesG Veronesi, M Lazzeroni, E Szabo, et al.
Pageof 10

Showing results (61-70 of 91) with videos related to

Sort By:
Pageof 10
European Journal of Cancer (Oxford, England : 1990)|September 24, 1999
Effect of tamoxifen on lipoprotein(a) and insulin-like growth factor-I (IGF-I) in healthy womenA Decensi, C Robertson, B Ballardini, et al.
Leukemia|April 6, 2012
N-(4-hydroxyphenyl)retinamide promotes apoptosis of resting and proliferating B-cell chronic lymphocytic leukemia cells and potentiates fludarabine and ABT-737 cytotoxicityS Bruno, F Ghiotto, C Tenca, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 20, 2013
Association of molecular subtypes with Ki-67 changes in untreated breast cancer patients undergoing pre-surgical trialsS Gandini, A Guerrieri-Gonzaga, G Pruneri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 19, 2010
Prognostic significance of Ki-67 labeling index after short-term presurgical tamoxifen in women with ER-positive breast cancerA DeCensi, A Guerrieri-Gonzaga, S Gandini, et al.
Nuklearmedizin. Nuclear Medicine|July 14, 2015
18F-FDG PET/CT is a prognostic biomarker in patients affected by bone metastases from breast cancer in comparison with 18F-NaF PET/CTA Piccardo, M Puntoni, S Morbelli, et al.
Breast Cancer Research and Treatment|January 5, 2002
Effect of low dose tamoxifen on the insulin-like growth factor system in healthy womenB Bonanni, H Johansson, S Gandini, et al.
Breast Cancer Research and Treatment|May 18, 1999
Effect of fenretinide on bone mineral density and metabolism in women with early breast cancerA Decensi, R Torrisi, A Gozza, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Effect of blood tamoxifen concentrations on surrogate biomarkers in a trial of dose reduction in healthy womenA Decensi, S Gandini, A Guerrieri-Gonzaga, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 6, 2001
Correlation between tamoxifen elimination and biomarker recovery in a primary prevention trialA Guerrieri-Gonzaga, L Baglietto, H Johansson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 13, 2015
Long-term effects of inhaled budesonide on screening-detected lung nodulesG Veronesi, M Lazzeroni, E Szabo, et al.
Pageof 10